Castle Biosciences Inc.
CSTL | NASDAQ
$34.99
-$0.35 (-0.99%)
At close: Sep 21, 2026, 4:00 PM ET
$34.99
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -2.83M | -12.83M | -24.16M | -12.24M | -9.47M | -5.07M | 18.25M | 6.08M | -3.1M | -30.8M | -57.47M | -75.5M | -88.85M | -71.72M | -67.14M | -52.95M | -44.49M | -51.64M | -31.29M | -29.75M | -22.55M | -15.13M |
Depreciation & Amortization | 7.59M | 14.94M | 40.77M | 42.76M | 42.49M | 42.42M | 16M | 13.45M | 13.09M | 12.78M | 12.33M | 11.95M | 11.7M | 11.28M | 10.54M | 9.15M | 7.32M | 5.33M | 3.41M | 2.12M | 1.15M | 614K |
Stock-Based Compensation | 23.51M | 44.49M | 45.89M | 45.93M | 46.85M | 48.82M | 50.32M | 50.68M | 50.7M | 50.37M | 51.22M | 49.34M | 45.49M | 41.43M | 36.32M | 33.25M | 29.26M | 25.25M | 21.74M | 17.85M | 14.76M | 11.65M |
Other Working Capital | 17.81M | -565K | 5.79M | 1.36M | -1.4M | 427K | 3.08M | 6.17M | 3.46M | 2.77M | 6.56M | 4.27M | 2.98M | 3.9M | 7.31M | 4.64M | 2.15M | -3.98M | 384K | -2.09M | -1.41M | 8.41M |
Other Non-Cash Items | -10.31M | -7.5M | -5.53M | -8.66M | -5.78M | -5.43M | -6.97M | -6.15M | -6.13M | -5.36M | -4.86M | -5.08M | -3.77M | -23.09M | -19.5M | -26.62M | -26.6M | -6.2M | -8.74M | 55K | 440K | 632K |
Deferred Income Tax | -791K | -5.47M | -6.23M | -7.63M | -2.49M | 631K | 1.4M | 3.47M | -1.78M | -236K | -223K | -25K | -25K | -1.99M | -1.88M | -1.84M | -1.84M | 123K | n/a | 1.4M | 1.4M | 1.4M |
Change in Working Capital | 25.47M | 14.62M | 13.6M | 1.62M | -9.11M | -15.71M | -14.13M | -8.44M | -12.02M | -13.78M | -6.63M | -10.89M | -5M | -1.58M | -7K | 573K | -2.99M | -9.65M | -4.1M | -8.3M | -8.65M | 7.33M |
Operating Cash Flow | 42.63M | 48.25M | 64.35M | 61.78M | 62.49M | 65.67M | 64.87M | 59.09M | 40.76M | 12.98M | -5.63M | -30.21M | -40.45M | -45.66M | -41.66M | -38.44M | -39.35M | -36.78M | -18.98M | -16.63M | -13.45M | 6.49M |
Capital Expenditures | -22.02M | -43.74M | -36.02M | -36.4M | -27.95M | -23.91M | -28.33M | -24.55M | -20.63M | -19.44M | -13.62M | -11.62M | -11.2M | -8.57M | -5.63M | -4.74M | -3.63M | -3.14M | -3.48M | -3.18M | -4.16M | -5M |
Cash Acquisitions | 18K | -18.7M | -18.71M | -18.71M | -18.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -305K | -305K | -305K | -30.31M | -30M | -63.18M | -63.18M | -33.18M | -33.18M | n/a |
Purchase of Investments | -95.88M | -195.42M | -188.71M | -198.63M | -185.37M | -193.41M | -205.73M | -210.79M | -215.83M | -219.75M | -189.08M | -139.57M | -221.13M | -164.77M | -134.69M | -131.81M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 110.43M | 196.21M | 190.73M | 195.85M | 177.75M | 170M | 183.9M | 171.75M | 177.95M | 186.7M | 186.5M | 138M | 95M | 50M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -43.88M | -2.1M | -7.66M | -5.54M | -5.54M | -5.55M | 18K | 14K | 12K | 13K | 13K | 196K | 195K | -25.91M | -25.92M | -26.1M | -26.1M | 10K | 10K | 7K | 5K | 3K |
Investing Cash Flow | -51.32M | -63.74M | -60.37M | -63.43M | -59.83M | -52.87M | -50.14M | -63.58M | -58.5M | -52.47M | -16.18M | -12.99M | -137.44M | -149.56M | -166.55M | -192.95M | -59.73M | -66.31M | -66.66M | -36.36M | -37.34M | -5M |
Debt Repayment | -82K | -139K | -141K | -140K | -133K | -87K | 9.9M | 9.89M | 9.88M | 9.86M | -142K | -140K | -137K | -133K | -122K | -96K | -63K | -32K | -8K | -24.03M | -26.53M | -27.36M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -13.84M | -12.81M | -9.03M | -8.1M | -6.28M | -6.36M | -4.14M | -1.67M | -2.45M | -2.24M | -2.16M | 389K | 729K | 1.16M | 1.64M | 2.49M | 2.44M | 2.28M | 1.9M | 3.07M | 3.38M | 73.03M |
Financial Cash Flow | -11.43M | -10.44M | -6.96M | -7.76M | -6M | -6.06M | 6.14M | 8.23M | 7.43M | 7.62M | -2.3M | 249K | 592K | 1.03M | 1.52M | 2.39M | 3.9M | 5.13M | 5.42M | 233.12M | 239.37M | 306.84M |
Net Cash Flow | -20.12M | -25.93M | -2.98M | -9.4M | -3.34M | 6.74M | 20.87M | 3.74M | -10.3M | -31.87M | -24.11M | -42.96M | -177.29M | -194.2M | -206.69M | -229M | -95.17M | -97.96M | -80.22M | 180.13M | 188.58M | 308.33M |
Free Cash Flow | 20.62M | 4.52M | 28.33M | 25.38M | 34.54M | 41.75M | 36.54M | 34.54M | 20.13M | -6.46M | -19.25M | -41.83M | -51.65M | -54.23M | -47.29M | -43.17M | -42.97M | -39.92M | -22.47M | -19.81M | -17.61M | 1.48M |
Adj. Free Cash Flow | -2.89M | -39.97M | -17.57M | -20.55M | -12.31M | -7.07M | -13.78M | -16.15M | -30.57M | -56.83M | -70.47M | -91.17M | -97.14M | -95.66M | -83.61M | -76.42M | -72.24M | -65.16M | -44.21M | -37.66M | -32.37M | -10.16M |
Maintenance CapEx | -29.73M | -35.06M | -32.66M | -29.81M | -17.27M | -8.01M | -10.43M | -6.26M | -3.96M | -5.62M | -2.65M | -2.65M | -2.72M | -1.06M | -70.81K | -70.81K | n/a | n/a | -110.8K | -699.8K | -2.57M | -4.17M |
Growth CapEx | 7.71M | -8.68M | -3.36M | -6.6M | -10.68M | -15.9M | -17.89M | -18.29M | -16.67M | -13.81M | -10.97M | -8.97M | -8.48M | -7.51M | -5.56M | -4.67M | -3.63M | -3.14M | -3.37M | -2.48M | -1.59M | -833.92K |
Owner Earnings | 12.91M | 13.19M | 31.68M | 31.97M | 45.22M | 57.66M | 54.43M | 52.83M | 36.8M | 7.36M | -8.28M | -32.86M | -43.17M | -46.72M | -41.73M | -38.51M | -39.35M | -36.78M | -19.09M | -17.33M | -16.02M | 2.32M |
Add to Watchlist
Select watchlists to add or remove CSTL